Posted inBenchmarking Biologic Drugs
118 biologics are expected to lose patent protection, representing a $232Bn of sales
Over the next decade (2025–2034), 118 biologics are expected to lose patent protection, presenting a $232Bn opportunity for biosimilars. Only 12 molecules set to lose patent protection from 2025 to…

